Dibash Kumar Das, PhD

Dibash K. Das serves as medical editor for Gastroenterology Advisor and oversees the day-to-day operation. He holds a Ph.D. in molecular, cellular, and developmental biology from the CUNY Graduate Center and an advanced certificate in clinical and translational investigation from Weill Cornell Medicine.

All articles by Dibash Kumar Das, PhD

General Oncology

EULAR Recommendations for the Management of Rheumatic Immune-Related Adverse Events Due to Cancer Immunotherapy

Dibash Kumar Das, PhD

June 4, 2020

A EULAR task force developed recommendations for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy.

Uncategorized

Evaluation of Primary Cardiac Lymphoma Incidence and Prognosis Using SEER Database

Dibash Kumar Das, PhD

May 13, 2020

SEER analysis reveals age, Ann Arbor stage, and chemotherapy as critical factors affecting prognosis in patients with primary cardiac lymphoma.

Leukemia

Dexrazoxane Reduces Short-Term Anthracycline-Associated Cardiac Dysfunction in Pediatric AML

Dibash Kumar Das, PhD

May 13, 2020

Pediatric patients with AML may benefit from dexrazoxane as a cardioprotectant during first-line anthracycline therapy.

Next post in Leukemia

Dibash Kumar Das, PhD

All articles by Dibash Kumar Das, PhD

EULAR Recommendations for the Management of Rheumatic Immune-Related Adverse Events Due to Cancer Immunotherapy

Evaluation of Primary Cardiac Lymphoma Incidence and Prognosis Using SEER Database

Dexrazoxane Reduces Short-Term Anthracycline-Associated Cardiac Dysfunction in Pediatric AML

Real-World Outcomes for Patients With CLL Differ in Community Setting